3-formyl-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1,3-oxazolidine-4-carboxamide
C16H17N3O3S — CID 170578120
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-formyl-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1,3-oxazolidine-4-carboxamide
3-formyl-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1,3-oxazolidine-4-carboxamide (PubChem CID 170578120) has the molecular formula C16H17N3O3S and a molecular weight of 331.40 g/mol. Its IUPAC name is 3-formyl-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1,3-oxazolidine-4-carboxamide.
Molecular Properties
| Compound Name | 3-formyl-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1,3-oxazolidine-4-carboxamide |
|---|---|
| PubChem CID | 170578120 |
| Molecular Formula | C16H17N3O3S |
| Molecular Weight | 331.40 g/mol |
| Exact Mass | 331.10 |
| IUPAC Name | 3-formyl-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1,3-oxazolidine-4-carboxamide |
| SMILES | Cc1ncsc1-c1ccc(CNC(=O)C2COCN2C=O)cc1 |
| InChI | InChI=1S/C16H17N3O3S/c1-11-15(23-8-18-11)13-4-2-12(3-5-13)6-17-16(21)14-7-22-10-19(14)9-20/h2-5,8-9,14H,6-7,10H2,1H3,(H,17,21) |
| InChIKey | CJFHETJTKRQPDD-UHFFFAOYSA-N |
| XLogP | 1.55 |
| TPSA | 71.53 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 331.40 |
| LogP ≤ 5 | 1.55 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170578120 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.